Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesInjuries, Poisonings and Toxic Effects of DrugsDRG 904-skin-grafts-for-injuries-with-cc-mcc
    Ask Trek AI about this page

    Skin Grafts for Injuries with CC/MCC: Inpatient Reimbursement Overview

    DRG 904 encompasses inpatient cases involving skin grafting for injury with a Complication or Comorbidity or a Major Complication or Comorbidity; it captures increased clinical complexity from comorbid conditions and postoperative complications. This grouping matters for inpatient reimbursement because the assigned Diagnosis-Related Group affects relative weights and payment levels under Medicare for resource use associated with grafting and concurrent conditions.

    Customize your policy alerts

    Sign up for drg 904 policy alerts

    Get alerted when payer policies referencing 904 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 904 Overview

    DRG 904 covers inpatient admissions for patients who receive skin grafts for traumatic injuries and have at least one Complication or Comorbidity or one Major Complication or Comorbidity. This Diagnosis-Related Group groups cases by the clinical resources associated with operative grafting for wounds and burns when additional comorbid conditions increase complexity. It matters for Medicare payment because the presence of Complication or Comorbidity or Major Complication or Comorbidity influences relative weight and reimbursement. Accurate coding of procedures and secondary diagnoses determines appropriate inpatient payment under Medicare.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute operative technique and graft integration studies: randomized or prospective cohort studies comparing different surgical approaches (eg, meshed versus sheet grafts, split-thickness versus full-thickness in select wounds) and adjuncts to optimize graft take in patients with traumatic skin loss or complex degloving injuries. These trials enroll hospitalized adult and pediatric trauma patients requiring operative skin grafting during the index admission, and measure early endpoints such as percent graft take at 7–14 days, need for reoperation, wound infection, and length of stay. Findings inform surgeons and hospital administrators about procedures that reduce reoperations and complications—key drivers of inpatient resource use and DRG cost variance.
    • Comparative effectiveness research on wound-bed optimization and perioperative care bundles: observational cohorts or pragmatic trials testing strategies such as negative-pressure wound therapy versus standard dressing, timing of grafting after initial debridement, and standardized perioperative antibiotic or glycemic-control bundles in patients with contaminated or high-risk wounds (eg, diabetes, vascular disease, or extensive tissue loss). These studies focus on moderateto-high risk inpatients to determine which pre-graft and perioperative protocols lower infection rates, shorten time to definitive closure, and reduce ICU transfers or prolonged hospitalization. Payers and hospital quality teams use this evidence to adopt care pathways that decrease complications and readmissions tied to higher DRG resource consumption.
    • Longitudinal outcomes and rehabilitation trials addressing functional recovery and post-discharge utilization: prospective follow-up studies and randomized or controlled rehabilitation interventions that evaluate scar contracture, range of motion, pain, return-to-function, staged reconstruction needs, and health-care utilization in the months to years after inpatient grafting for injury. These trials enroll survivors of major skin loss who were discharged after grafting and assess outcomes such as need for revision surgeries, durable outpatient wound-care costs, prosthetic or orthotic needs, and health-related quality of life. Results are relevant to payers and discharge planners because they identify interventions that reduce downstream costs, prevent costly readmissions or revisions, and improve long-term independence and return to work.

    Related Codes

    901-WOUND-DEBRIDEMENTS-FOR-INJURIES-WITH-MCC

    Wound Debridements for Injuries with MCC: Inpatient Reimbursement Overview

    902-WOUND-DEBRIDEMENTS-FOR-INJURIES-WITH-CC

    Wound Debridements for Injuries with CC: Inpatient Reimbursement Overview

    903-WOUND-DEBRIDEMENTS-FOR-INJURIES-WITHOUT-CC-MCC

    Wound Debridements for Injuries without CC/MCC: Inpatient Reimbursement Overview

    905-SKIN-GRAFTS-FOR-INJURIES-WITHOUT-CC-MCC

    Skin Grafts for Injuries without CC/MCC: Inpatient Reimbursement Overview

    906-HAND-PROCEDURES-FOR-INJURIES

    Hand Procedures for Injuries: Inpatient Reimbursement Overview

    907-OTHER-O-R-PROCEDURES-FOR-INJURIES-WITH-MCC

    Other O.R. Procedures for Injuries with MCC: Inpatient Reimbursement Overview

    908-OTHER-O-R-PROCEDURES-FOR-INJURIES-WITH-CC

    Other O.R. Procedures for Injuries with CC: Inpatient Reimbursement Overview

    909-OTHER-O-R-PROCEDURES-FOR-INJURIES-WITHOUT-CC-MCC

    Other O.R. Procedures for Injuries without CC/MCC: Inpatient Reimbursement Overview

    913-TRAUMATIC-INJURY-WITH-MCC

    Traumatic Injury with MCC: Inpatient Reimbursement Overview

    914-TRAUMATIC-INJURY-WITHOUT-MCC

    Traumatic Injury without MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 19

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.